“The vast majority of prevention is done at the primary care level, so it’s extremely important that we communicate both our messages and the key guidelines for prevention to the larger primary care audience.” – Nathan D. Wong, PhD
The vast majority of prevention is done at the primary care level, so it’s extremely important that we communicate both our messages and the key guidelines for prevention to the larger primary care audience. Preventive Cardiology has several extremely valuable figures, tables, and summaries of recommendations for clinical management of various risk factors. The book appeals to the primary care audience as well as to specialists including cardiologists, endocrinologists, and others who are involved in preventive cardiology work.
I was interested in health promotion and nutrition even when I was in elementary school. In high school, I became interested in prevention and began learning about some of the important prevention programs. While I was in school for my PhD, I had the opportunity to work on the Framingham Heart Study, where I worked with some of the giants in the field. Their inspiration really solidified my interests.
Preventive Cardiology is particularly strong in the area of cardiovascular risk assessment and diagnostic testing. We have several excellent chapters that focus on initial risk evaluation using, for example, the Framingham and other risk scores, as well as other approaches like biomarkers and subclinical disease screening modalities like CT, MRI, and ultrasound. Also, besides chapters that focus on management of key risk factors such as hypertension, dyslipidemia, and diabetes, we have some particular novel chapters such as on genetics, heart failure prevention, integrative medicine, and the role of treatment adherence and performance measures in CVD prevention.
Nathan D. Wong, PhD is Professor and Director of the Heart Disease Prevention Program in the Division of Cardiology at University of California, Irvine School of Medicine. He is also Adjunct Professor of Epidemiology at UC Irvine and UCLA. Holding PhD and MPH degrees in epidemiology from Yale University, he is also a Fellow of the American College of Cardiology and the American Heart Association Council on Epidemiology and Prevention. He is Immediate Past President of the American Society for Preventive Cardiology.
Dr. Wong has been an investigator or collaborator with numerous large-scale NIH-sponsored studies including the Framingham Heart Study, Women’s Health Initiative, Antihypertensive Lipid-Lowering to Prevent Heart Attack Trial, and the Multiethnic Study of Atherosclerosis. He regularly lectures nationally and internationally on his research in various topics in preventive cardiology and is a member of Who’s Who in America and Who’s Who in the World.
With over 20 years of experience as a cardiovascular epidemiologist, Dr. Wong has edited or co-edited four clinical references. He has also authored or co-authored over 200 peer-reviewed manuscripts in his principal research areas of subclinical atherosclerosis, metabolic syndrome, diabetes, and lipids and hypertension, and serves on the editorial boards of several noted journals in the areas of cardiovascular disease and diabetes.
Related Authors: Roger Blumenthal, MD, FACC, FAHA; JoAnne Foody, MD, FACC, FAHA
